Atlas Trials

Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus

Clinical trial NCT00248313 · COMPLETED

Trial details

NCT number
NCT00248313
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Kidney Disease
Start date
2000-07-01
Enrollment
470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.